We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Portable Prostate Cancer Test Uses Single Drop of Blood to Deliver Results in Minutes

By LabMedica International staff writers
Posted on 06 Jan 2022
Print article
Illustration
Illustration

A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African American men.

The proof-of-concept test developed by researchers at the Cornell University (Ithaca, NY, USA) is inexpensive and uses a test strip and a small cube-shaped 1.6-inch reader to quantify a marker of prostate cancer - called prostate-specific antigen (PSA) - from a drop of blood in minutes. The kit comes with a test strip, similar to those found in at-home COVID-19 antigen or pregnancy tests. Users would draw a drop of blood and apply it to the test strip, and in about 15 minutes, two lines appear on the strip.

The color of the two lines is due to 150-nanometer gold nanoshells, which greatly enhance the test’s sensitivity to detect PSAs and make the lines appear more intense in their presence, according to the researchers. While a pregnancy test gives a positive or negative result, the cube reader senses the intensity of the test strip lines and then calculates and displays a measurement of PSA concentration in the blood. While a different PSA test kit developed by a private company has been approved by the FDA, it works by putting a blood sample into a microfluidic channel and has a larger bench-top analyzer, making it less portable and more expensive to own and operate.

“We’ll be able to take a drop of blood in a community setting such as a barbershop and be able to deliver results in 10 to 15 minutes right there, which can indicate when somebody needs to come in for further tests,” said Dr. Saurabh Mehta, the Janet and Gordon Lankton Professor in the Division of Nutritional Sciences and the paper’s senior author.

“Another advantage of test strips is that the technology to make them really cheap or mass produce them has been around for many years,” said Balaji Srinivasan, a research associate in Mehta’s research group and the paper’s first author, who estimates that PSA test kits may be mass produced and sold for a few dollars each.

Related Links:
Cornell University 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more